Kaiser Permanente
Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Kaiser Permanente researchers have good news for patients, surgeons, anesthesiologists, and hospital administrators who have had to put off elective surgery because of a positive COVID-19 test. Among fully vaccinated patients, there may not be an elevated risk with surgery soon after COVID-19.
Kaiser Permanente Northern California’s life-saving Advance Alert Monitor (AAM) program — an early detection system that helps care teams predict when hospitalized patients are at risk for clinical deterioration — has been recognized by The Joint Commission and National Quality Forum.
New Kaiser Permanente research finds health care system costs were lower for people who live in greener areas.
Some people who get blood clots in their lungs may be able to skip a visit to the emergency department and be managed safely by their primary care physicians, a new Kaiser Permanente analysis suggests.
Gabriel Escobar, MD, retires in December after 30 years as a research scientist with DOR and as regional director for hospital operations research for Kaiser Permanente Northern California (KPNC).
A follow-up program for Kaiser Permanente Northern California patients discharged from the hospital was associated with reduced readmissions without increased mortality, new research in the journal BMJ suggests.
Health systems could use data from routine clinical care to identify the onset of upcoming COVID-19 surges as many as 6 weeks before they occur, Kaiser Permanente researchers found in a study published in the journal BMJ Open.
Kaiser Permanente study by adjunct investigator and oncologist/hematologist Minggui Pan, MD, PhD, quantifies impact of a virtual tumor board for rare type of cancer.
A sophisticated system that analyzes electronic data about hospital patients, identifies those at risk of deteriorating, and issues an alert to a centralized team of specially trained nurses resulted in a lower mortality rate, Kaiser Permanente researchers reported in the New England Journal of Medicine.
Kaiser Permanente study finds new classification and automated referral system benefits patients.
